Clinical Study

Insulin Therapy and Body Weight, Body Composition and Muscular Strength in Patients with Type 2 Diabetes Mellitus

Table 1

Evolution from M0 to M6 of body parameters and Hb1Ac levels during insulin therapy in patients with type 2 diabetes mellitus. Results are mean (SD), 𝑃 indicates the significance of the difference versus the baseline value (NS: nonsignificant).

3 months (M3)6 months (M6)

Weight change (kg)+ 0.7 (2.3)+ 3.1 (2.2) 𝑃 < . 0 0 8
Fat mass change (kg) 0 .2 (3.1)+ 3.1 (2.7) 𝑃 < . 0 1 2
Waist circumference change (cm) 0.3 (3.8)+ 1.7 (4.5) 𝑃 < . 0 0 4
Fat free mass change (kg)+ 0.9 (2.9) 𝑃 = . 1 5 (NS) 0.1 (2.6) 𝑃 = . 8 2 (NS)
Muscle strength change (kg)+ 0.4 (2.9) 𝑃 = 0 . 5 7 + 0.4 (4.2) 𝑃 = . 8 7
HbA1c change (%) 2.4 (1.7) 𝑃 < 0 . 0 0 0 5 2.2 (1.7) 𝑃 < . 0 0 0 5
Insulin doses (U/kg)0.41 (0.32)0.44 (0.27)